SFN inhibited tau protein phosphorylation in an in vivo model of AD via the PI3K/Akt/GSK-3β pathway and suppressed anti-inflammatory markers such as NF-κB, NO, TNF-α, and IL-6 [89]. The gene discussed is MAPT; the disease is Alzheimer disease.